"From evidence to practice" - Insights from the multidisciplinary team on the optimal integration of GLP-1 receptor agonists in obesity management services

被引：1
作者：
Brown, Adrian [1 ,2 ,3 ]
Mellor, Duane [4 ,5 ]
Makaronidis, Janine [1 ,2 ,6 ]
Shuttlewood, Emma [7 ]
Miras, Alexander Dimitri [8 ]
Pournaras, Dimitri J. [9 ]
机构：
[1] UCL, Ctr Obes Res, London, England
[2] Univ Coll London Hosp NHS Trust, Bariatr Ctr Weight Management & Metab Surg, London, England
[3] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth & Care Res, London, England
[4] Univ Hosp Leicester NHS Trust, Nutr & Dietet, Leicester, England
[5] Aston Univ, Aston Med Sch, Birmingham, England
[6] Barts Hlth NHS Trust, Royal London Hosp, Dept Diabet & Metab, London, England
[7] Univ Hosp Coventry & Warwickshire NHS Trust, Specialist Weight Management Serv, Coventry, England
[8] Ulster Univ, Sch Nursing, Derry, North Ireland
[9] North Bristol Natl Hlth Serv Trust, Dept Bariatr & Metab Surg, Bristol, England
来源：
NUTRITION BULLETIN | 2024年 / 49卷 / 03期
关键词：
WEIGHT-LOSS MAINTENANCE; DOUBLE-BLIND; 3.0; MG; LIRAGLUTIDE; EFFICACY; PLACEBO; SAFETY; REGAIN; TRIAL;
D O I：
10.1111/nbu.12700
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
引用
收藏
页码：257 / 263
页数：7
相关论文
共 50 条
  • [21] GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice
    Coke, Lola A.
    Deedwania, Prakash C.
    Hinnen, Debbie
    Magwire, Melissa
    Miller, Nancy H.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2022, 34 (02) : 418 - 440
  • [22] Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?
    Kaplan, Jennifer M.
    Zaman, Adnin
    Abushamat, Layla A.
    CURRENT CARDIOLOGY REPORTS, 2024, 26 (09) : 1011 - 1019
  • [23] Use of GLP-1 Receptor Agonists for the Management of Type 1 Diabetes: A Pediatric Perspective
    Shenker, Michal Nevo
    Shalitin, Shlomit
    HORMONE RESEARCH IN PAEDIATRICS, 2024,
  • [24] From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists
    Dave, Bhavarth P.
    Chorawala, Mehul R.
    Shah, Ishika V.
    Shah, Nidhi N.
    Bhagat, Shivam U.
    Prajapati, Bhupendra G.
    Thakkar, Pratik C.
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [25] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection
    Page, Laura C.
    Freemark, Michael
    CURRENT OBESITY REPORTS, 2020, 9 (04) : 391 - 401
  • [26] Efficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis
    Pan, Xin-Hui
    Tan, Bryan
    Chin, Yip Han
    Lee, Ethan Cheng Zhe
    Kong, Gwyneth
    Chong, Bryan
    Kueh, Martin
    Khoo, Chin Meng
    Mehta, Anurag
    Majety, Priyanka
    Grandhi, Gowtham R.
    Dimitriadis, Georgios K.
    Foo, Roger
    Chew, Nicholas W. S.
    Le Roux, Carel W.
    Mamas, Mamas A.
    Chan, Mark Y.
    OBESITY, 2024, 32 (05) : 840 - 856
  • [27] GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Physiology to Clinical Outcomes
    Rojano Toimil, Alba
    Ciudin, Andreea
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [28] GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
    Kawanami, Daiji
    Takashi, Yuichi
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [29] Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
    Jalleh, Ryan J.
    Rayner, Chris K.
    Hausken, Trygve
    Jones, Karen L.
    Camilleri, Michael
    Horowitz, Michael
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (10): : 957 - 964
  • [30] Therapeutic management of atypical antipsychotic-related metabolic dysfunctions using GLP-1 receptor agonists: A systematic review
    Vasiliu, Octavian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (01)
12345